October 01, 2026
What is Qui Tam? Whistleblower’s Guide to Qui Tam Lawsuits
Content Updated: October 1, 2026 Qui tam is a type of lawsuit based on an ancient writ in common law that allows a private person, known as a qui tam relator, to prosecute a lawsuit for the government...
September 23, 2026
CFTC Grants 15 Whistleblower Awards Totaling Over $158 Million
Last week, the Commodity Futures Trading Commission (CFTC) announced that it has granted at least 15 financial awards to whistleblowers this year — five awards granted on June 1st totaling $8 million...
Posted In Whistleblower Law Insights
September 18, 2026
Judith King: A Nurse’s Whistleblower Case
Judith King is a nurse whistleblower who brought a qui tam lawsuit under the False Claims Act, alleging that Sharp Memorial Hospital defrauded Medicare through fraudulent reimbursement claims tied to its...
Lack of Medical Necessity and the False Claims Act
Unnecessary medical care provided to patients, often referred to as a lack of medical necessity, can result in false claims being submitted to government programs, like Medicare or Medicaid. It can also...
Posted In Qui Tam
September 17, 2026
HCA Whistleblower James Alderson
Who Is HCA Whistleblower James Alderson? James F. Alderson, a client of Phillips & Cohen, was a financial officer at a Montana hospital managed by Quorum Health Resources Inc. Alderson alleged that...
September 10, 2026
Eleventh Circuit Rejects Constitutional Challenge to FCA Qui Tam Provisions
Last week, in United States ex rel. Zafirov v. Florida Medical Associates, LLC, the Eleventh Circuit rejected a constitutional challenge to the False Claims Act’s (“FCA”) qui tam provisions, reversing...
Posted In Whistleblower Law Insights
September 03, 2026
Pharmaceutical Whistleblower & Fraud Cases
A pharmaceutical whistleblower is someone who reports suspected fraud or misconduct involving a drug manufacturer, pharmacy, pharmaceutical distributor, pharmacy benefit manager (PBM), or another organization...
AI Whistleblowers: Reporting AI Fraud and Misconduct
Artificial Intelligence (“AI”) pervades current discussions in government, business, and academia. While the potential for this rapidly developing technology is both exciting and unnerving, some...
Posted In Whistleblower Law Insights
September 02, 2026
Ruling Affirms the False Claims Act does not violate the Appointments Clause of Article II of the Constitution
Phillips & Cohen Statement RE: United States ex rel. Zafirov v. Florida Medical Associates, Inc. Yesterday, in United States ex rel. Zafirov v. Florida Medical Associates, Inc., the Eleventh Circuit...
Posted In Phillips & Cohen News
August 21, 2026
DOJ National Fraud Enforcement Division Outlines Its Priorities
In an August 13 memorandum, the Department of Justice laid out the enforcement priorities for its National Fraud Enforcement Division, setting forth the five top areas of focus. The Trump administration...
Posted In Whistleblower Law Insights